Pharmaceutical Spending in U.S. Highest of OECD Countries Despite U.S.’ Much Greater Use of Generics

Pharmaceutical Spending in U.S. Highest of OECD Countries Despite U.S.’ Much Greater Use of GenericsP “Compared with peer countries, the United States spends about 200% more per capita on prescription drugs. In 2016, the United States spent approximately $329 billion on prescription drugs, a number likely to grow. Recent OECD data show that Americans spend […]

Continue reading

Treatment Adherence Improves when Prescription Medications are Free

Treatment Adherence Improves when Prescription Medications are Free Importance Nonadherence to treatment with medicines is common globally, even for life-saving treatments. Cost is one important barrier to access, and only some jurisdictions provide medicines at no charge to patients. Objective To determine whether providing essential medicines at no charge to outpatients who reported not being […]

Continue reading

1 in 4 People in the U.S. Report Difficulty Paying for Prescriptions

1 in 4 People in the U.S. Report Difficulty Paying for Prescriptions “This Visualizing Health Policy infographic spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices. Prescription drug spending rose sharply in 2014, driven by growth in expenditures on specialty drugs, including medications to treat cancer and hepatitis C. Medicare’s spending […]

Continue reading

U.S. Pays More for Drugs than Other Nations, would Negotiate Down with Medicare for All

U.S. Pays More for Drugs than Other Nations, would Negotiate Down with Medicare for All “U.S. payers are currently charged substantially more for drugs than payers in other countries (Danzon and Furukawa, 2008), which may be partially attributable to the fact that Medicare is currently barred from negotiating drug prices on behalf of enrollees. Within […]

Continue reading